The third-generation anti-CD30 CAR T-cells specifically homing to the tumor and mediating powerful antitumor activity.
Zhang S, Gu C, Huang L, Wu H, Shi J, Zhang Z, Zhou Y, Zhou J, Gao Y, Liu J, Leng Y, Liu X, Zhang Q, Huang L, Tong X, Young KH, Li J, Zhu H, Zhang T.
Zhang S, et al. Among authors: zhu h.
Sci Rep. 2022 Jun 21;12(1):10488. doi: 10.1038/s41598-022-14523-0.
Sci Rep. 2022.
PMID: 35729339
Free PMC article.